Michael J. Yang - Jun 11, 2025 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: Director
Signature: /s/ Kristen Williams, Attorney-in-Fact
Stock symbol: PCRX
Transactions as of: Jun 11, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/13/2025, 04:17 PM
Previous filing: Jan 17, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
YANG MICHAEL J.	Director	C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE	/s/ Kristen Williams, Attorney-in-Fact	2025-06-13	0001702283

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Award	$0	+6.16K	+85.24%	$0.00	13.4K	Jun 11, 2025	Direct	F1

Showing 1 to 1 of 1 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Award	$0	+11.3K		$0.00	11.3K	Jun 11, 2025	Common Stock	11.3K	$24.34	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
F2	The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.